ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,271
similar
All similar
Record
: found
Abstract
: not found
Conference Proceedings
: not found
Vadadustat, an oral HIF-PHI, is not associated with risk of neoplasm in patients with anemia due to CKD
Author(s):
R Agarwal
,
D Vargo
,
W. LUO
,
C. Solinsky
,
GM Chertow
Publication date:
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
IUCN Red List of Ecosystems
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
4,271
Efficacy and dose requirements of vadadustat are independent of systemic inflammation and prior erythropoiesis-stimulating agent (ESA) dose in patients with non-dialysis dependent chronic kidney disease (CKD)
Authors:
VH Haase
,
BS Spinowitz
,
PE Pergola
Efficacy and safety of vadadustat compared to darbepoetin alfa on anemia in patients with chronic kidney disease: a meta-analysis
Authors:
Qiong Huang
,
Zhenyi Liao
,
Xiaoyan Liu
…
Nonequilibrium Dynamics of Symmetry Breaking in Lambda Phi^4 Field Theory
Authors:
Yuval Kluger
,
Fred Cooper
,
Emil Mottola
…
See all similar
Cited by
1
Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, in Rodents
Authors:
Heather Kowalski
,
Debie Hoivik
,
Michael Rabinowitz
See all cited by